<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en">
  <head>
    <title>IBD_logical_model</title>
    <meta name="created-at" content="2023-05-05 16:00:38"/>
    <meta name="generator" content="GINsim"/>
    <style type="text/css">
table {border-collapse: collapse;}

.L1{}

.table th, table td{border: 1px solid black}
</style>
    <script type="text/javascript">
<![CDATA[function getElementsByContent(content, tagName) {
	var elements = new Array();
	var nodes = document.getElementsByTagName(tagName);
	for (var i = 0, node; node = nodes[i]; i++) {
			if (node.innerHTML.indexOf(content) != -1) elements.push(node);
	}
	return elements;
}

function nextSiblingOfType(node, nodeName, validAttributes) {
	if (validAttributes == null) validAttributes = function (node) {return true;};
	node = node.nextSibling;
	while ((node.nodeName != nodeName || (node.nodeName == nodeName && !validAttributes(node))) && node.nextSibling != null)
		node = node.nextSibling;
	return node;
}

function makeStableStatesClickable() {
	var tables = getElementsByContent('Stable states', 'td');
	var i;
	for (i = 0 ; i - tables.length != 0 ; i++) {
		var td_stableState = tables[i];//the td containing Stable states
		var tr = tables[i].parentNode;
		p = document.createElement('p');
		p.innerHTML = tables[i].innerHTML + ' (';
		a = document.createElement('a');
		a.setAttribute('href', 'javascript:toggle(this, "stableState'+i+'")');
		a.innerHTML = 'View';
		p.appendChild(a);
		p.innerHTML += ')';
		tables[i].replaceChild(p, tables[i].firstChild) ;

		tr = nextSiblingOfType(tr, tr.nodeName, function (node) {
			node = nextSiblingOfType(node.firstChild, tables[i].nodeName, null);
			if (node.getAttribute("colspan") != null && node.getAttribute("colspan") > 3) return true;
			return false;
		})
		var td_new = nextSiblingOfType(tr.firstChild, tables[i].nodeName, null);
		td = document.createElement('td');
		td.setAttribute('colspan', '5');
		p = document.createElement('p');
		p.innerHTML = td_new.innerHTML;
		p.setAttribute('id', 'stableState'+i);
		p.style.display = 'none';
		td.appendChild(p);
		tr.replaceChild(td, td_new);
	}
}

function toggle(a, id) {
	elm = document.getElementById(id);
	if (elm.style.display == 'none') {
		elm.style.display = 'inline';
		a.innerHTML = 'Hide';
	} else {
		elm.style.display = 'none'
		a.innerHTML = 'View';
	}
}

window.onload = makeStableStatesClickable;
]]>    </script>
    <style type="text/css">    </style>
  </head>
  <body>
    <h1>Description of the model "IBD_logical_model"</h1>
    <img src="GINsim documentation.xhtml_FILES/model.png"/>
    <h2>Annotation</h2>
    <p>The logical model represents the behaviour of intestinal epithelial cells (IECs) during the chronic stage of inflammatory bowel disease (IBD) in response to the main cytokines and pathogen-related entities present in the local environment. <br /><br />The main cytokines that account for the characteristic cytokine milieu are TNF and IFNg (namely derived from Th1 cells), and IL-17 and IL-22 (namely derived from Th17 cells). Pathways activated by these cytokines are acquired and modified from the psoKC (psoriatic keratinocyte) model created by Eirini Tsirvouli et al. <br /><br />Type I and III interferon signaling is also included in the model, where several of the IBD-associated genes are involved in these pathways (e.g. JAK2, TYK2, STAT1). Moreover, since microbial dysbiosis plays an important role in development and relapse of IBD, some bacterial components are added (LPS, PGN and MDP) as inputs which triggers the activation of PPRs and their downstream pathways. Finally, signaling through IL1R was included in the model, since IL1b plays a central role in the intestinal inflammation cascade.</p>
    <ol class="links">
      <li>
        <a href=":"></a>
      </li>
    </ol>
    <p/>
    <h2>Nodes</h2>
    <table class="table">
      <tr class="">
        <th>ID</th>
        <th>Val</th>
        <th>Logical function</th>
        <th>Comment</th>
      </tr>
      <tr>
        <th>LPS</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Lipopolysaccharide</p>
          <ol class="links">
            <li>
              <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509312/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509312/</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>PGN</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Peptidoglycan</p>
          <ol class="links">
            <li>
              <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/peptidoglycan">https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/peptidoglycan</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>MDP</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Muramyl dipeptide</p>
          <ol class="links">
            <li>
              <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241611/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241611/</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>NOD2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>MDP</li>
          </ul>
        </td>
        <td>
          <p>Nucleotide-binding oligomerization domain-containing protein 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9HC29/entry">https://www.uniprot.org/uniprotkb/Q9HC29/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>MDP</th>
              <td>
                <p>NOD2 recognizes the peptidoglycan product muramyl dipeptide (MDP), which modulates both innate and adaptive immune responses.</p>
                <ol class="links">
                  <li>
                    <a href="Ramos GP, Papadakis KA. Mechanisms of disease:inflammatory bowel diseases. In: Mayo Clinic Proceedings. vol. 94. Elsevier; 2019. p. 155-65.">Ramos GP, Papadakis KA. Mechanisms of disease:inflammatory bowel diseases. In: Mayo Clinic Proceedings. vol. 94. Elsevier; 2019. p. 155-65.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TLR4</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>LPS</li>
          </ul>
        </td>
        <td>
          <p>Toll-like receptor 4 </p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O00206/entry">https://www.uniprot.org/uniprotkb/O00206/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>LPS</th>
              <td>
                <p>TLR4 in intestinal epithelial cells has been shown both inflammatory and homeostatic roles following binding of its cognate ligand lipopolysaccharide (LPS). </p>
                <ol class="links">
                  <li>
                    <a href="QI, Xuefeng, et al. Lipopolysaccharide upregulated intestinal epithelial cell expression of Fn14 and activation of Fn14 signaling amplify intestinal TLR4-mediated inflammation. Frontiers in cellular and infection microbiology, 2017, 7:315.">QI, Xuefeng, et al. Lipopolysaccharide upregulated intestinal epithelial cell expression of Fn14 and activation of Fn14 signaling amplify intestinal TLR4-mediated inflammation. Frontiers in cellular and infection microbiology, 2017, 7:315.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TLR2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>PGN</li>
          </ul>
        </td>
        <td>
          <p>Toll-like receptor 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O60603/entry">https://www.uniprot.org/uniprotkb/O60603/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>PGN</th>
              <td>
                <p>Toll-like receptor (TLR) 2, a member of the TLR family that is constitutively expressed in IECs, recognizes conserved microbe-associated molecular patterns of both gram-negative and gram-positive bacteria, such as lipoteichoic acid (LTA), lipoarabinomannan, lipoproteins and peptidoglycan (PGN). </p>
                <ol class="links">
                  <li>
                    <a href="GU, Min Jeong, et al. Barrier protection via Toll-like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol. Veterinary research, 2016, 47.1:1-11.">GU, Min Jeong, et al. Barrier protection via Toll-like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol. Veterinary research, 2016, 47.1:1-11.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>ATG16L1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(NOD2 | NOD1) &amp; !mTORC1</li>
          </ul>
        </td>
        <td>
          <p>Autophagy-related protein 16-1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q676U5/entry">https://www.uniprot.org/uniprotkb/Q676U5/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>mTORC1</th>
              <td>
                <p>MTORC1 serves as a major suppressor of autophagy.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526825/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526825/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>NOD2</th>
              <td>
                <p>MDP stimulation of epithelial cells, macrophages, and dendritic cells activated autophagy and nuclear factor κB and mitogen-activated protein kinase signaling; it also increased killing of Salmonella. These responses depended on ATG16L1 and Nod2 expression and were impaired by CD-associated NOD2 variants. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/20637199/">https://pubmed.ncbi.nlm.nih.gov/20637199/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>NOD1</th>
              <td>
                <p>Travassos et al. showed that NOD1 and NOD2 can recruit ATG16L1 to the plasma membrane.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TLR3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>dsRNA</li>
          </ul>
        </td>
        <td>
          <p>Toll-like receptor 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O15455/entry">https://www.uniprot.org/uniprotkb/O15455/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>dsRNA</th>
              <td>
                <p>TLR3 is a type of PRR that senses endogenous dsRNA from damaged tissues and viruses, where emerging evidence indicates that TLR3-signalling is a major factor in homeostasis and wound repair.</p>
                <ol class="links">
                  <li>
                    <a href="Østvik AE, Svendsen TD, Granlund AvB, Doseth B, Skovdahl HK, Bakke I, et al. Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn’s disease. Journal of Crohn’s and Colitis. 2020;14(7):920-34. 12">Østvik AE, Svendsen TD, Granlund AvB, Doseth B, Skovdahl HK, Bakke I, et al. Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn’s disease. Journal of Crohn’s and Colitis. 2020;14(7):920-34. 12</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>dsRNA</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Double-stranded RNA</p>
          <ol class="links">
            <li>
              <a href="https://www.nature.com/articles/s41580-021-00430-1">https://www.nature.com/articles/s41580-021-00430-1</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>MYD88</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TLR4 | TLR2 | TLR5 | IL1R</li>
          </ul>
        </td>
        <td>
          <p>Myeloid differentiation primary response protein MyD88 </p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q99836/entry">https://www.uniprot.org/uniprotkb/Q99836/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL1R</th>
              <td>
                <p>MyD88 mediates signaling downstream of TLRs and IL-1 family members.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.jci.org/articles/view/154993">https://www.jci.org/articles/view/154993</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TLR4</th>
              <td>
                <p>Medzhitov's lab showed the crucial role of TLR4/MyD88 signaling for the maintenance of the intestinal homeostasis and barrier repair during acute DSS colitis in microbiota dependent manner (53). </p>
                <ol class="links">
                  <li>
                    <a href="Semin I, Ninnemann J, Bondareva M, Gimaev I, Kruglov AA. Interplay Between Microbiota, Toll-Like Receptors and Cytokines for the Maintenance of Epithelial Barrier Integrity. Front Med (Lausanne). 2021;8:644333. Published 2021 May 28. doi:10.3389/fmed.2021.644333">Semin I, Ninnemann J, Bondareva M, Gimaev I, Kruglov AA. Interplay Between Microbiota, Toll-Like Receptors and Cytokines for the Maintenance of Epithelial Barrier Integrity. Front Med (Lausanne). 2021;8:644333. Published 2021 May 28. doi:10.3389/fmed.2021.644333</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TLR5</th>
              <td>
                <p> All TLRs expect for TLR3 signal-transmit through MyD88 to the activation of NF-κB and p38/c-Jun N-terminal kinase (JNK). </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/18506843/">https://pubmed.ncbi.nlm.nih.gov/18506843/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TLR2</th>
              <td>
                <p>MyD88 is a cytosolic adapter molecule connecting TLRs and IL-1Rs to the IRAK complex.</p>
                <ol class="links">
                  <li>
                    <a href="Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev. 2011;24(3):490-497. doi:10.1128/CMR.00001-11">Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev. 2011;24(3):490-497. doi:10.1128/CMR.00001-11</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IRAK_complex</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>MYD88 &amp; !Tollip</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Interleukin-1 receptor-associated kinase 1 <br />Interleukin-1 receptor-associated kinase 4<br />Interleukin-1 receptor-associated kinase-like 2<br />Interleukin-1 receptor-associated kinase 3 </p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9NWZ3/entry">https://www.uniprot.org/uniprotkb/Q9NWZ3/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O43187/entry">https://www.uniprot.org/uniprotkb/O43187/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9Y616/entry">https://www.uniprot.org/uniprotkb/Q9Y616/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>Tollip</th>
              <td>
                <p>Inhibition by Tollip is mediated through its ability to potently suppress the activity of IL-1 receptor-associated kinase (IRAK) after TLR activation. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11751856/">https://pubmed.ncbi.nlm.nih.gov/11751856/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>MYD88</th>
              <td>
                <p>MyD88 is a cytosolic adapter molecule connecting TLRs and IL-1Rs to the IRAK complex. IRAK complex (Fig. 1), which consists of two active kinases (IRAK-1 and IRAK-4) and two noncatalytic subunits (IRAK-2 and IRAK-3/M). </p>
                <ol class="links">
                  <li>
                    <a href="Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev. 2011;24(3):490-497. doi:10.1128/CMR.00001-11">Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev. 2011;24(3):490-497. doi:10.1128/CMR.00001-11</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TRAF6</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!TNFAIP3 &amp; (IRAK_complex | TRAF3IP2 | TICAM1)</li>
          </ul>
        </td>
        <td>
          <p>TNF receptor-associated factor 6</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9Y4K3/entry">https://www.uniprot.org/uniprotkb/Q9Y4K3/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRAF3IP2</th>
              <td>
                <p>triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/Q16552/entry">https://www.uniprot.org/uniprotkb/Q16552/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TNFAIP3</th>
              <td>
                <p>A20 (also known as the TNFα-induced protein 3; TNFAIP3). A20 inhibits NF-κB signaling by removing polyubiquitin chains form TNF receptor associated factor 6 (TRAF6) and receptor interacting protein 2 (RIP2) during TLR/IL-1R and NOD signaling, respectively.</p>
                <ol class="links">
                  <li>
                    <a href="https://link.springer.com/article/10.1007/s10787-017-0309-4">https://link.springer.com/article/10.1007/s10787-017-0309-4</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TICAM1</th>
              <td>
                <p>TRIF was also demonstrated to interact with TRAF6 via a TRAF6-binding motif [19]. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632169/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632169/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IRAK_complex</th>
              <td>
                <p>TLR4 signaling leads to interleukine-1 receptor associated kinase-1 (IRAK1) and tumor necrosis factor (TNF) receptor associated factor6 (TRAF6) activation which ultimately results in nuclear factor- ĸB (NF-ĸB) activation as the main transcription factor of inflammatory cytokines. </p>
                <ol class="links">
                  <li>
                    <a href="Hajivalili M, Pourgholi F, Majidi J, et al. G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner. Cell Mol Biol (Noisy-le-grand). 2016;62(4):1-5. Published 2016 Apr 30.">Hajivalili M, Pourgholi F, Majidi J, et al. G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner. Cell Mol Biol (Noisy-le-grand). 2016;62(4):1-5. Published 2016 Apr 30.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>NFKB</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!NFKBIA &amp; !PPARG &amp; IKBKB</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Nuclear factor NF-kappa-B p105 subunit<br />Transcription factor p65</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P19838/entry">https://www.uniprot.org/uniprotkb/P19838/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q04206/entry">https://www.uniprot.org/uniprotkb/Q04206/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>PPARG</th>
              <td>
                <p>Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) and c-Jun NH2-terminal kinase (JNK)/p38 mitogen-activated protein kinase (MAPK) pathway activation. PPARs are important for IBD because many of these signaling pathways are downregulated by the activation of PPARγ.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00730/full">https://www.frontiersin.org/articles/10.3389/fphar.2020.00730/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>NFKBIA</th>
              <td>
                <p>The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/gene/4792#summary">https://www.ncbi.nlm.nih.gov/gene/4792#summary</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IKBKB</th>
              <td>
                <p>In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/O14920/entry">https://www.uniprot.org/uniprotkb/O14920/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TNF</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | CREB1</li>
          </ul>
        </td>
        <td>
          <p>Tumor necrosis factor</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01375/entry">https://www.uniprot.org/uniprotkb/P01375/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>CREB1</th>
              <td>
                <p>CREB is induced by a variety of growth factors and inflammatory signals and subsequently mediates the transcription of genes containing a cAMP-responsive element. Several immune-related genes possess this cAMP-responsive element, including IL-2, IL-6, IL-10, and TNF-α. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/21084670/">https://pubmed.ncbi.nlm.nih.gov/21084670/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>TNFA gene expression itself is regulated by NFκB. </p>
                <ol class="links">
                  <li>
                    <a href="Ruder B, Atreya R, Becker C. Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. Int J Mol Sci. 2019;20(8):1887. Published 2019 Apr 16. doi:10.3390/ijms20081887">Ruder B, Atreya R, Becker C. Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. Int J Mol Sci. 2019;20(8):1887. Published 2019 Apr 16. doi:10.3390/ijms20081887</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TICAM1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TLR3</li>
          </ul>
        </td>
        <td>
          <p>TIR domain-containing adapter molecule 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q8IUC6/entry">https://www.uniprot.org/uniprotkb/Q8IUC6/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TLR3</th>
              <td>
                <p>TLR3 signals through the adaptor molecule TRIF.</p>
                <ol class="links">
                  <li>
                    <a href="McAllister CS, Lakhdari O, Pineton de Chambrun G, et al. TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo. J Immunol. 2013;190(1):418-427. doi:10.4049/jimmunol.1202756">McAllister CS, Lakhdari O, Pineton de Chambrun G, et al. TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo. J Immunol. 2013;190(1):418-427. doi:10.4049/jimmunol.1202756</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TBK1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TICAM1</li>
          </ul>
        </td>
        <td>
          <p>Serine/threonine-protein kinase TBK1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9UHD2/entry">https://www.uniprot.org/uniprotkb/Q9UHD2/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TICAM1</th>
              <td>
                <p>TBK1 is the central kinase of the MAVS, STING, and TRIF signaling complexes.</p>
                <ol class="links">
                  <li>
                    <a href=":Ruyuan, Zhou &amp; Zhang, Qian &amp; Xu, Pinglong. (2020). TBK1, a central kinase in innate immune sensing of nucleic acids and beyond. Acta biochimica et biophysica Sinica. 52. 10.1093/abbs/gmaa051. ">Ruyuan, Zhou &amp; Zhang, Qian &amp; Xu, Pinglong. (2020). TBK1, a central kinase in innate immune sensing of nucleic acids and beyond. Acta biochimica et biophysica Sinica. 52. 10.1093/abbs/gmaa051. </a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IRF_complex</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TBK1</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Interferon regulatory factor 3 <br />Interferon regulatory factor 7 </p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q14653/entry">https://www.uniprot.org/uniprotkb/Q14653/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q92985/entry">https://www.uniprot.org/uniprotkb/Q92985/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TBK1</th>
              <td>
                <p>Upon activation, TBK1 or IKKɛ (hereafter called TBK1/IKKɛ) phosphorylates the transcription factors IRF3 and IRF7 to trigger their dimerization and nuclear translocation, leading to induction of IFN-I gene expression.</p>
                <ol class="links">
                  <li>
                    <a href="Shi JH, Xie X, Sun SC. TBK1 as a regulator of autoimmunity and antitumor immunity. Cell Mol Immunol. 2018;15(8):743-745. doi:10.1038/cmi.2017.165">Shi JH, Xie X, Sun SC. TBK1 as a regulator of autoimmunity and antitumor immunity. Cell Mol Immunol. 2018;15(8):743-745. doi:10.1038/cmi.2017.165</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNB</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IRF_complex | IRF1</li>
          </ul>
        </td>
        <td>
          <p>Interferon beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01574/entry">https://www.uniprot.org/uniprotkb/P01574/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IRF1</th>
              <td>
                <p>IRF1 is a transcription factor that can provide additional positive feedback stimulation of ISGs.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35790340/">https://pubmed.ncbi.nlm.nih.gov/35790340/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IRF_complex</th>
              <td>
                <p>phosphorylation and translocation of IRF3 and IRF7, initiating the transcription of interferon (IFN)-β, IFN-λ.</p>
                <ol class="links">
                  <li>
                    <a href="Guo L, Xu XQ, Zhou L, et al. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. Front Immunol. 2018;9:247. Published 2018 Feb 19. doi:10.3389/fimmu.2018.00247">Guo L, Xu XQ, Zhou L, et al. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. Front Immunol. 2018;9:247. Published 2018 Feb 19. doi:10.3389/fimmu.2018.00247</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNL1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IRF_complex</li>
          </ul>
        </td>
        <td>
          <p>Interferon lambda-1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q8IU54/entry">https://www.uniprot.org/uniprotkb/Q8IU54/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IRF_complex</th>
              <td>
                <p>phosphorylation and translocation of IRF3 and IRF7, initiating the transcription of interferon (IFN)-β, IFN-λ.</p>
                <ol class="links">
                  <li>
                    <a href="Guo L, Xu XQ, Zhou L, et al. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. Front Immunol. 2018;9:247. Published 2018 Feb 19. doi:10.3389/fimmu.2018.00247">Guo L, Xu XQ, Zhou L, et al. Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. Front Immunol. 2018;9:247. Published 2018 Feb 19. doi:10.3389/fimmu.2018.00247</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL23</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Interleukin-23 subunit alpha<br />Interleukin-12 subunit beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9NPF7/entry">https://www.uniprot.org/uniprotkb/Q9NPF7/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P29460/entry">https://www.uniprot.org/uniprotkb/P29460/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p> NF-κB target genes, such as IL-12 and IL-23, are associated with human IBD.</p>
                <ol class="links">
                  <li>
                    <a href="Liu, T., Zhang, L., Joo, D. et al. NF-κB signaling in inflammation. Sig Transduct Target Ther 2, 17023 (2017). https://doi.org/10.1038/sigtrans.2017.23">Liu, T., Zhang, L., Joo, D. et al. NF-κB signaling in inflammation. Sig Transduct Target Ther 2, 17023 (2017). https://doi.org/10.1038/sigtrans.2017.23</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TNFRSF1A</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TNF_e</li>
          </ul>
        </td>
        <td>
          <p>Tumor necrosis factor receptor superfamily member 1A</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/P19438">https://www.uniprot.org/uniprot/P19438</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TNF_e</th>
              <td>
                <p>The interaction of TNF-alpha with TNF receptor 1 and receptor 2 (TNFR-1, TNFR-2) activates several signal transduction pathways, leading to the diverse functions of TNF-alpha. </p>
                <ol class="links">
                  <li>
                    <a href="van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment:molecular insights, antitumor effects, and clinical utility. Oncologist. 2006 Apr;11(4):397-408. doi: 10.1634/theoncologist.11-4-397. PMID: 16614236.">van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment:molecular insights, antitumor effects, and clinical utility. Oncologist. 2006 Apr;11(4):397-408. doi: 10.1634/theoncologist.11-4-397. PMID: 16614236.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IKBKB</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(TRAF2 &amp; RIPK1) | AKT | IKBKG</li>
          </ul>
        </td>
        <td>
          <p>Inhibitor of nuclear factor kappa-B kinase subunit beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O14920/entry">https://www.uniprot.org/uniprotkb/O14920/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRAF2</th>
              <td>
                <p>We found that TNF-R1-mediated IKK activation requires both RIP and TRAF2 proteins. Although TRAF2 or RIP can be independently recruited to the TNF-R1 complex, neither one of them alone is capable of transducing the TNF signal that leads to IKK activation.</p>
              </td>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>AKT activates IKK</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>RIPK1</th>
              <td>
                <p>We found that TNF-R1-mediated IKK activation requires both RIP and TRAF2 proteins. Although TRAF2 or RIP can be independently recruited to the TNF-R1 complex, neither one of them alone is capable of transducing the TNF signal that leads to IKK activation.</p>
                <ol class="links">
                  <li>
                    <a href="Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1:TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity. 2000 Apr;12(4):419-29. doi: 10.1016/s1074-7613(00)80194-6. PMID: 10795740.">Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1:TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity. 2000 Apr;12(4):419-29. doi: 10.1016/s1074-7613(00)80194-6. PMID: 10795740.</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IKBKG</th>
              <td>
                <p>Upon activation, the IKK complex phosphorylates the inhibitor of kappa B (IKB), leading to its degradation and thereby facilitating nuclear translocation of NF-kappa B and transcription of genes involved in inflammation, immunity and cell survival. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007618/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007618/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TRADD</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TNFRSF1A</li>
          </ul>
        </td>
        <td>
          <p>Tumor necrosis factor receptor type 1-associated DEATH domain protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q15628">https://www.uniprot.org/uniprot/Q15628</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TNFRSF1A</th>
              <td>
                <p>The death domain of tnfrsf1a provides a novel molecular interface that interacts specifically with the death domain of tradd.</p>
                <ol class="links">
                  <li>
                    <a href="McDermott MF. TNF and TNFR biology in health and disease. Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):619-35. PMID: 11502070.">McDermott MF. TNF and TNFR biology in health and disease. Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):619-35. PMID: 11502070.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>FADD</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TRADD</li>
          </ul>
        </td>
        <td>
          <p>FAS-associated death domain protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q13158">https://www.uniprot.org/uniprot/Q13158</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRADD</th>
              <td>
                <p>The strong interaction between tradd and fadd occurs via their death domains.</p>
                <ol class="links">
                  <li>
                    <a href="Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996 Jan 26;84(2):299-308. doi: 10.1016/s0092-8674(00)80984-8. PMID: 8565075.">Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996 Jan 26;84(2):299-308. doi: 10.1016/s0092-8674(00)80984-8. PMID: 8565075.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TRAF2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TRADD</li>
          </ul>
        </td>
        <td>
          <p>TNF receptor-associated factor 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q12933">https://www.uniprot.org/uniprot/Q12933</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRADD</th>
              <td>
                <p>Upon stimulation with TNFα, TNFR1 recruits TRADD, which provides a scaffold for the assembly of complex I at the plasma membrane by binding with RIP1, TRAF2 and cIAP.</p>
                <ol class="links">
                  <li>
                    <a href="Liu X, Shi F, Li Y, Yu X, Peng S, Li W, Luo X, Cao Y. Post-translational modifications as key regulators of TNF-induced necroptosis. Cell Death Dis. 2016 Jul 7;7(7):e2293. doi: 10.1038/cddis.2016.197. PMID: 27383048; PMCID: PMC4973344.">Liu X, Shi F, Li Y, Yu X, Peng S, Li W, Luo X, Cao Y. Post-translational modifications as key regulators of TNF-induced necroptosis. Cell Death Dis. 2016 Jul 7;7(7):e2293. doi: 10.1038/cddis.2016.197. PMID: 27383048; PMCID: PMC4973344.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>RIPK1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>FADD</li>
          </ul>
        </td>
        <td>
          <p>Receptor-interacting serine/threonine-protein kinase 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q13546">https://www.uniprot.org/uniprot/Q13546</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRAF6</th>
              <td>
                <p> TRAF6 recruits RIP-1, which activates the TAK1 complex following MAPK activation. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2014.00461/full">https://www.frontiersin.org/articles/10.3389/fimmu.2014.00461/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>FADD</th>
              <td>
                <p>We show that tradd interacts strongly with rip;rip is a serinethreonine kinase that is recruited by tradd to tnfr1 in a tnf-dependent process.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/8612133/">https://pubmed.ncbi.nlm.nih.gov/8612133/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TNF_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Tumor necrosis factor</p>
          <ol class="links">
            <li>
              <a href=":www.uniprot.org/uniprotkb/P01375/entry">www.uniprot.org/uniprotkb/P01375/entry</a>
            </li>
            <li>
              <a href=":"></a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>NFKBIA</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB &amp; !IKBKB</li>
          </ul>
        </td>
        <td>
          <p>NF-kappa-B inhibitor alpha</p>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>NF-κB is found in the cytoplasm in its inactive form with the inhibitor of NF-κB subunit.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IKBKB</th>
              <td>
                <p>The protein encoded by this gene phosphorylates the inhibitor in the inhibitor/NF-kappa-B complex, causing dissociation of the inhibitor and activation of NF-kappa-B. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/gene/3551#summary">https://www.ncbi.nlm.nih.gov/gene/3551#summary</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL36A</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-36 alpha</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9UHA7/entry">https://www.uniprot.org/uniprotkb/Q9UHA7/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Known factors that control IL-36 expression are pro-inflammatory cytokines including IL-18, IL-1β and IFN-γ, as well as the TLR ligands, CpG, LPS, Poly I:C.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/33501638/">https://pubmed.ncbi.nlm.nih.gov/33501638/</a>
                  </li>
                  <li>
                    <a href=":"></a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>Known factors that control IL-36 expression are pro-inflammatory cytokines including IL-18, IL-1β and IFN-γ.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/33501638/">https://pubmed.ncbi.nlm.nih.gov/33501638/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL1B</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | AP1</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-1 beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01584/entry">https://www.uniprot.org/uniprotkb/P01584/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Activation of the NF-κB/Rel transcription family, by nuclear translocation of cytoplasmic complexes, plays a central role in inflammation through its ability to induce transcription of proinflammatory genes (1).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.jci.org/articles/view/11830">https://www.jci.org/articles/view/11830</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p> IL-1beta and GM-CSF. These mediators are downstream targets for the transcription factors activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB).</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11488985/">https://pubmed.ncbi.nlm.nih.gov/11488985/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNB_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interferon beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01574/entry">https://www.uniprot.org/uniprotkb/P01574/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IFNAR</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IFNB_e | IFNA1_e</li>
          </ul>
        </td>
        <td>
          <p>Interferon alpha/beta receptor <br />Interferon alpha/beta receptor 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P17181/entry">https://www.uniprot.org/uniprotkb/P17181/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P48551/entry">https://www.uniprot.org/uniprotkb/P48551/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IFNB_e</th>
              <td>
                <p>all type I IFNs signal through a common heterodimeric receptor composed of low‐ (IFNAR1) and high‐affinity (IFNAR2) receptor components 4 (see Figure 1).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNA1_e</th>
              <td>
                <p>all type I IFNs signal through a common heterodimeric receptor composed of low‐ (IFNAR1) and high‐affinity (IFNAR2) receptor components 4 (see Figure 1).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>JAK1_TYK2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(IL22R | IFNAR | IFNLR) &amp; !PTPN2</li>
          </ul>
        </td>
        <td>
          <p>Tyrosine-protein kinase JAK1<br />Non-receptor tyrosine-protein kinase TYK2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P23458/entry">https://www.uniprot.org/uniprotkb/P23458/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P29597/entry">https://www.uniprot.org/uniprotkb/P29597/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL22R</th>
              <td>
                <p> The IL22R signal is transmitted through the activation of JAK1 (mobile kinase IL22R1) and Tyk2 (mobile kinase IL10R2). </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29037907/">https://pubmed.ncbi.nlm.nih.gov/29037907/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PTPN2</th>
              <td>
                <p>The PTPN2 gene encodes the T-cell<br />protein tyrosine phosphatase (TCPTP), which is essential for regulation of in-<br />flammation. TCPTP partly modulates inflammation via control of inflamma-<br />tory signaling pathways, by namely inhibiting Janus kinase (JAK) enzymes,<br />and signal transducer and activator of transcription (STAT) molecules.</p>
                <ol class="links">
                  <li>
                    <a href="https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/">https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNLR</th>
              <td>
                <p>Engagement of all IFNs with their receptors initiates downstream signaling events, namely, activation of the JAK–STAT signaling cascade. JAK1, TYK2, and potentially JAK2 are phosphorylated and activated.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2017.01707/full">https://www.frontiersin.org/articles/10.3389/fimmu.2017.01707/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNAR</th>
              <td>
                <p>Activation of interferon alpha/beta receptor (IFNAR) triggers Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2).</p>
                <ol class="links">
                  <li>
                    <a href="Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.">Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>ISGF3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>JAK1_TYK2</li>
          </ul>
        </td>
        <td>
          <p>Signal transducer and activator of transcription factor 1<br />Signal transducer and activator of transcription factor 2<br />Interferon regulatory factor 9</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P42224/entry">https://www.uniprot.org/uniprotkb/P42224/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P52630/entry">https://www.uniprot.org/uniprotkb/P52630/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q00978/entry">https://www.uniprot.org/uniprotkb/Q00978/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>JAK1_TYK2</th>
              <td>
                <p>Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) which phosphorylates STAT1 and STAT2. The STAT1/STAT2 heterodimer can interact with IRF9 to create IFN-stimulated gene factor 3 (ISGF3).</p>
                <ol class="links">
                  <li>
                    <a href="Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.">Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>ISG15</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>ISGF3</li>
          </ul>
        </td>
        <td>
          <p>Ubiquitin-like protein ISG15</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P05161/entry">https://www.uniprot.org/uniprotkb/P05161/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>ISGF3</th>
              <td>
                <p>IFN-stimulated gene factor 3 (ISGF3) which binds to IFN-stimulated response DNA element (ISRE) and induces transcription of ISGs</p>
                <ol class="links">
                  <li>
                    <a href="Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.">Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CXCL8</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT3 | AP1</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-8</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P10145/entry">https://www.uniprot.org/uniprotkb/P10145/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Activation of NF-kB and MAPKs in IECs triggers secretion of interleukins and chemokines, such as C-X-C motif chemokine ligand 8 (CXCL8).</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32020185/">https://pubmed.ncbi.nlm.nih.gov/32020185/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>Colonic expression of interleukin 6 (IL-6), the STAT3 target gene SOCS3, the neutrophil chemoattractants IL-8, CXCL1, and CXCL3, and the neutrophil products S100A8, S100A9, and S100A12 were increased in patients carrying the STAT3 "A" risk allele.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22197944/">https://pubmed.ncbi.nlm.nih.gov/22197944/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p>Activation of NF-kB and MAPKs in IECs triggers secretion of interleukins and chemokines, such as C-X-C motif chemokine ligand 8 (CXCL8).</p>
                <ol class="links">
                  <li>
                    <a href="https://academic.oup.com/ecco-jcc/article/14/7/920/5727513?login=false">https://academic.oup.com/ecco-jcc/article/14/7/920/5727513?login=false</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CXCL1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>Growth-regulated alpha protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P09341/entry">https://www.uniprot.org/uniprotkb/P09341/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>blocking the activation of NF-kappaB by MG-132 or antisense p50 oligonucleotide transfection resulted in down-regulated expression of chemokines such as CXCL1, CXCL8, and CCL2.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/12296854/">https://pubmed.ncbi.nlm.nih.gov/12296854/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CCL20</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>C-C motif chemokine 20</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P78556/entry">https://www.uniprot.org/uniprotkb/P78556/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p> Tumour necrosis factor-α [TNF-α] is a powerful inducer of CCL20 in intestinal epithelial cells.</p>
                <ol class="links">
                  <li>
                    <a href="https://academic.oup.com/ecco-jcc/article/11/5/603/2422319">https://academic.oup.com/ecco-jcc/article/11/5/603/2422319</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL17_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interleukin-17A</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q16552/entry">https://www.uniprot.org/uniprotkb/Q16552/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IL17R</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IL17_e</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-17 Receptor A<br />Interleukin-17 Receptor C</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q96F46">https://www.uniprot.org/uniprot/Q96F46</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL17_e</th>
              <td>
                <p>Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/Q16552/entry">https://www.uniprot.org/uniprotkb/Q16552/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TRAF3IP2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IL17R</li>
          </ul>
        </td>
        <td>
          <p>TRAF3IP2/CIKS: E3 ubiquitin ligase TRAF3IP2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O43734/entry">https://www.uniprot.org/uniprotkb/O43734/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL17R</th>
              <td>
                <p>Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/Q16552/entry">https://www.uniprot.org/uniprotkb/Q16552/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TAK1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TRAF6 | RIPK2 | (TRAF6 &amp; RIPK1)</li>
          </ul>
        </td>
        <td>
          <p>TAK1/ M3K7: Mitogen-Activated Protein Kinase Kinase Kinase 7</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O43318/entry">https://www.uniprot.org/uniprotkb/O43318/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRAF6</th>
              <td>
                <p>Intriguingly, TGF-beta-induced TRAF6-mediated Lys 63-linked polyubiquitylation of TAK1 Lys 34 correlates with TAK1 activation. Our data show that TGF-beta specifically activates TAK1 through interaction of TbetaRI with TRAF6, whereas activation of Smad2 is not dependent on TRAF6.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/18758450/">https://pubmed.ncbi.nlm.nih.gov/18758450/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>RIPK1</th>
              <td>
                <p>TRAF6 recruits RIP-1, which activates the TAK1 complex following MAPK activation. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2014.00461/full">https://www.frontiersin.org/articles/10.3389/fimmu.2014.00461/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>RIPK2</th>
              <td>
                <p>This leads to RIPK2 activation, which depends on autophosphorylation in residues Ser176 and Tyr474, an essential and enhancing site respectively (36, 37), and downstream activation of transforming growth factor beta-activated kinase 1 (TAK1) (38–40). TAK1 consecutively phosphorylates the IKK complex triggering NF-κB and MAPK pathway activation.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>P38</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>JAK1_TYK2 | TAK1</li>
          </ul>
        </td>
        <td>
          <p>P38/MAPK14: Mitogen-activated protein kinase 14</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q16539/entry">https://www.uniprot.org/uniprotkb/Q16539/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>JAK1_TYK2</th>
              <td>
                <p>intracellular kinases such as janus kinase-1 (IL-22R1 activator) and tyrosine kinase-2 (IL-10R2 activator) activate various signaling factors including P38, Akt (Protein Kinase B), mitogen-activated protein kinase, extracellular signal-regulated kinase-1/2, and c-Jun N-terminal kinase.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32365282/">https://pubmed.ncbi.nlm.nih.gov/32365282/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TAK1</th>
              <td>
                <p>Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/O43318/entry">https://www.uniprot.org/uniprotkb/O43318/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>JNK1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TAK1 | JAK1_TYK2</li>
          </ul>
        </td>
        <td>
          <p>JNK1/ MAPK8: Mitogen-activated protein kinase 8</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P45983/entry">https://www.uniprot.org/uniprotkb/P45983/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>JAK1_TYK2</th>
              <td>
                <p>intracellular kinases such as janus kinase-1 (IL-22R1 activator) and tyrosine kinase-2 (IL-10R2 activator) activate various signaling factors including P38, Akt (Protein Kinase B), mitogen-activated protein kinase, extracellular signal-regulated kinase-1/2, and c-Jun N-terminal kinase.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32365282/">https://pubmed.ncbi.nlm.nih.gov/32365282/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TAK1</th>
              <td>
                <p>Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/O43318/entry">https://www.uniprot.org/uniprotkb/O43318/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>AP1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!PPARG &amp; (P38 | JNK1)</li>
          </ul>
        </td>
        <td>
          <p>AP-1 transcription factor complex FOS-JUN</p>
          <ol class="links">
            <li>
              <a href="https://www.ebi.ac.uk/complexportal/complex/CPX-486">https://www.ebi.ac.uk/complexportal/complex/CPX-486</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>JNK1</th>
              <td>
                <p>Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/O43318/entry">https://www.uniprot.org/uniprotkb/O43318/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PPARG</th>
              <td>
                <p>Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) and c-Jun NH2-terminal kinase (JNK)/p38 mitogen-activated protein kinase (MAPK) pathway activation. PPARs are important for IBD because many of these signaling pathways are downregulated by the activation of PPARγ.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00730/full">https://www.frontiersin.org/articles/10.3389/fphar.2020.00730/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>P38</th>
              <td>
                <p>Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.uniprot.org/uniprotkb/O43318/entry">https://www.uniprot.org/uniprotkb/O43318/entry</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>STAT3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(mTORC1 | IL22R) &amp; !PTPN2</li>
          </ul>
        </td>
        <td>
          <p>Signal transducer and activator of transcription 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P40763/entry">https://www.uniprot.org/uniprotkb/P40763/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL22R</th>
              <td>
                <p>After binding of IL-22 to the IL-22R1/IL-10R2 complex, intracellular signaling pathways are activated, which eventually results in phosphorylation of the serine and tyrosine amino acids in the signal transducer and activator of transcription-1 (STAT1), STAT3, and STAT5 signaling molecules. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32365282/">https://pubmed.ncbi.nlm.nih.gov/32365282/</a>
                  </li>
                  <li>
                    <a href=":"></a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>mTORC1</th>
              <td>
                <p>mTORC1 activates COX-2 transcription via phosphorylating STAT3 and enhancing it’s binding to the COX-2 promoter.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/s41385-018-0018-3">https://www.nature.com/articles/s41385-018-0018-3</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PTPN2</th>
              <td>
                <p>The PTPN2 gene encodes the T-cell<br />protein tyrosine phosphatase (TCPTP), which is essential for regulation of in-<br />flammation. TCPTP partly modulates inflammation via control of inflamma-<br />tory signaling pathways, by namely inhibiting Janus kinase (JAK) enzymes,<br />and signal transducer and activator of transcription (STAT) molecules.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409587/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409587/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL22_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interleukin-22</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9GZX6/entry">https://www.uniprot.org/uniprotkb/Q9GZX6/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IL22R</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IL22_e</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-22 receptor subunit alpha-1<br />Interleukin-10 receptor subunit beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprot/Q8N6P7">https://www.uniprot.org/uniprot/Q8N6P7</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q08334/entry">https://www.uniprot.org/uniprotkb/Q08334/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL22_e</th>
              <td>
                <p>Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/10875937/">https://pubmed.ncbi.nlm.nih.gov/10875937/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>ROS</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>DUOX2</li>
          </ul>
        </td>
        <td>
          <p>Reactive oxygen species</p>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>DUOX2</th>
              <td>
                <p> (DUOX2), which prevents bacterial colonization of the mucosa through the production of hydrogen peroxide (H2O2).</p>
                <ol class="links">
                  <li>
                    <a href="https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416">https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>STAT1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(JAK1_TYK2 | JAK1_JAK2 | IL22R) &amp; !PTPN2</li>
          </ul>
        </td>
        <td>
          <p>Signal transducer and activator of transcription 1-alpha/beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P42224/entry">https://www.uniprot.org/uniprotkb/P42224/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL22R</th>
              <td>
                <p>After binding of IL-22 to the IL-22R1/IL-10R2 complex, intracellular signaling pathways are activated, which eventually results in phosphorylation of the serine and tyrosine amino acids in the signal transducer and activator of transcription-1 (STAT1), STAT3, and STAT5 signaling molecules. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32365282/">https://pubmed.ncbi.nlm.nih.gov/32365282/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PTPN2</th>
              <td>
                <p>The PTPN2 gene encodes the T-cell<br />protein tyrosine phosphatase (TCPTP), which is essential for regulation of in-<br />flammation. TCPTP partly modulates inflammation via control of inflamma-<br />tory signaling pathways, by namely inhibiting Janus kinase (JAK) enzymes,<br />and signal transducer and activator of transcription (STAT) molecules.</p>
                <ol class="links">
                  <li>
                    <a href="https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/">https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>JAK1_TYK2</th>
              <td>
                <p>Both type I and type II IFNs also induce the formation of STAT1–STAT1.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/nri1604">https://www.nature.com/articles/nri1604</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>JAK1_JAK2</th>
              <td>
                <p>IFNγ signal transduction predominantly activates STAT1 homodimers.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>AKT</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!PTPA &amp; (PI3K | JAK1_TYK2)</li>
          </ul>
        </td>
        <td>
          <p>AKT1: RAC-alpha serine/threonine-protein kinase<br />AKT2: RAC-beta serine/threonine-protein kinase</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P31749/entry">https://www.uniprot.org/uniprotkb/P31749/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P31751/entry">https://www.uniprot.org/uniprotkb/P31751/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>PTPA</th>
              <td>
                <p>AKT is inhibited by protein phosphatase-2A (PP2A), which in turn may be inactivated by ROS.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>JAK1_TYK2</th>
              <td>
                <p>intracellular kinases such as janus kinase-1 (IL-22R1 activator) and tyrosine kinase-2 (IL-10R2 activator) activate various signaling factors including P38, Akt (Protein Kinase B), mitogen-activated protein kinase, extracellular signal-regulated kinase-1/2, and c-Jun N-terminal kinase.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32365282/">https://pubmed.ncbi.nlm.nih.gov/32365282/</a>
                  </li>
                  <li>
                    <a href=":"></a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PI3K</th>
              <td>
                <p>AKT is a downstream target of PI3Ks.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CASP8</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>(TRADD &amp; FADD) | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Caspase-8</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q14790/entry">https://www.uniprot.org/uniprotkb/Q14790/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRADD</th>
              <td>
                <p>Extrinsic apoptosis relies on the formation of a death-inducing signaling complex (DISC), which always includes FADD and caspase-8. In the case of ligation of TNFR1, another adapter, tumor necrosis factor receptor type 1-associated DEATH domain (TRADD), is first engaged, which in turn recruits FADD, and TRADD is required for apoptosis induced by TNF, but not for that induced by other death receptor ligands. Other death receptors engage FADD directly.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/28462525/">https://pubmed.ncbi.nlm.nih.gov/28462525/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>These apoptosis ISGs were predominantly proapoptotic genes (including BAK1, CASP3, CASP8, CASP10, FAS, TNFSF10A, and TNFRSF10A) and were stimulated by IFN-II or IFN-I treatments.</p>
                <ol class="links">
                  <li>
                    <a href="https://journals.aai.org/immunohorizons/article/6/7/416/234080/Transcriptional-and-Cytotoxic-Responses-of-Human">https://journals.aai.org/immunohorizons/article/6/7/416/234080/Transcriptional-and-Cytotoxic-Responses-of-Human</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>FADD</th>
              <td>
                <p>Extrinsic apoptosis relies on the formation of a death-inducing signaling complex (DISC), which always includes FADD and caspase-8. In the case of ligation of TNFR1, another adapter, tumor necrosis factor receptor type 1-associated DEATH domain (TRADD), is first engaged, which in turn recruits FADD, and TRADD is required for apoptosis induced by TNF, but not for that induced by other death receptor ligands. Other death receptors engage FADD directly.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/28462525/">https://pubmed.ncbi.nlm.nih.gov/28462525/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>RIPK3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>RIPK1 &amp; !CASP8</li>
          </ul>
        </td>
        <td>
          <p>Receptor-interacting serine/threonine-protein kinase 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9Y572/entry">https://www.uniprot.org/uniprotkb/Q9Y572/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>CASP8</th>
              <td>
                <p>Noteworthy, complex IIa-associated active caspase-8 and caspase-8/FLIPL heterodimers, which have a limited enzymatic activity, cleave RIPK1 and RIPK3 and prevent so complex IIb triggered formation of necroptosis-inducing oligomeric RIPK1/RIPK3 aggregates.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fcell.2019.00091/full">https://www.frontiersin.org/articles/10.3389/fcell.2019.00091/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>RIPK1</th>
              <td>
                <p>When caspase-8 activity is inhibited the amyloid-like RIP1/RIP3 necrosome is formed.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/27308332/">https://pubmed.ncbi.nlm.nih.gov/27308332/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>PI3K</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!PTEN &amp; (IL22R | IFNAR | IFNGR | ROS)</li>
          </ul>
        </td>
        <td>
          <p>PI3K/ PK3CD: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O00329/entry">https://www.uniprot.org/uniprotkb/O00329/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL22R</th>
              <td>
                <p>IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22840496/">https://pubmed.ncbi.nlm.nih.gov/22840496/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>PTEN</th>
              <td>
                <p>The activity of PI3Ks can be inhibited by PTEN, which also has protein and lipid phosphatase activity (33). Therefore, PTEN negatively regulates AKT signaling (34). <br />The PI3K/AKT/mTOR signaling pathway is activated in Crohn’s disease by PTEN downregulation, which may be involved in the pathogenesis this disease.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNAR</th>
              <td>
                <p>Both type I and type II IFNs regulate activation of the phosphatidylinositol 3-kinase (PI3K)-signalling pathway.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/nri1604">https://www.nature.com/articles/nri1604</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNGR</th>
              <td>
                <p>Both type I and type II IFNs regulate activation of the phosphatidylinositol 3-kinase (PI3K)-signalling pathway.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/nri1604">https://www.nature.com/articles/nri1604</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>ROS</th>
              <td>
                <p>ROS activate nuclear factor‑κB (NF‑κB) via IκB kinase (IKK) through the PI3K/AKT/PTEN pathway. <br />Reactive oxygen species (ROS) play an important role in inflammation processes.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>PTEN</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!ROS</li>
          </ul>
        </td>
        <td>
          <p>Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P60484/entry">https://www.uniprot.org/uniprotkb/P60484/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>ROS</th>
              <td>
                <p> ROS also activate PI3K/AKT and inactivate phosphatase and tensin homolog (PTEN).</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>PTPA</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!ROS</li>
          </ul>
        </td>
        <td>
          <p>Serine/threonine-protein phosphatase 2A activator</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q15257/entry">https://www.uniprot.org/uniprotkb/Q15257/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>CREB1</th>
              <td>
                <p> PP2A-Aα is positively regulated by multiple transcription factors including Ets-1, CREB.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22827437/">https://pubmed.ncbi.nlm.nih.gov/22827437/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>ROS</th>
              <td>
                <p>AKT is inhibited by protein phosphatase-2A (PP2A), which in turn may be inactivated by ROS.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25352295/">https://pubmed.ncbi.nlm.nih.gov/25352295/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IKBKG</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>TRAF6 | TAK1</li>
          </ul>
        </td>
        <td>
          <p>IKBKG/ NEMO: NF-kappa-B essential modulator</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9Y6K9/entry">https://www.uniprot.org/uniprotkb/Q9Y6K9/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>TRAF6</th>
              <td>
                <p>TRAF6 is a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11057907/">https://pubmed.ncbi.nlm.nih.gov/11057907/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TAK1</th>
              <td>
                <p>This result suggests that ikkgamma/nemo binds to the polyubiquitinated tak1.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/20038579/">https://pubmed.ncbi.nlm.nih.gov/20038579/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>SOCS3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT3 | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Suppressor of cytokine signaling 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O14543/entry">https://www.uniprot.org/uniprotkb/O14543/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene is induced by various cytokines, including IL6, IL10, and interferon (IFN)-gamma.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOCS3">https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOCS3</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>STAT3 activation can also induce the expression of suppressors of cytokine signaling (SOCS) 3 that has been shown to play an important role in the suppression of acute colitis.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743999/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743999/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>FOXO3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!AKT</li>
          </ul>
        </td>
        <td>
          <p>Forkhead box protein O3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O43524/entry">https://www.uniprot.org/uniprotkb/O43524/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>FOXO phosphorylation by Akt impairs its DNA binding activity and promotes its interaction with the chaperone protein 14-3-3, resulting in nuclear exclusion, cytoplasmic accumulation and ubiquitin-proteasome pathway-dependent degradation, thus promoting cell survival.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S1043661815002133">https://www.sciencedirect.com/science/article/abs/pii/S1043661815002133</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>Flagellin</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Flagellin</p>
          <ol class="links">
            <li>
              <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/flagellin">https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/flagellin</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>TLR5</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>Flagellin</li>
          </ul>
        </td>
        <td>
          <p>Toll-like receptor 5</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O60602/entry">https://www.uniprot.org/uniprotkb/O60602/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>Flagellin</th>
              <td>
                <p>Mainly, TLR5 recognizes bacterial flagellin.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797585/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797585/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CREB1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>AKT</li>
          </ul>
        </td>
        <td>
          <p>Cyclic AMP-responsive element-binding protein 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P16220/entry">https://www.uniprot.org/uniprotkb/P16220/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>Our results support the notion that Akt/PKB promotes cell survival, at least in part, by stimulating the expression of cellular genes via the CREB/CBP nuclear transduction pathway.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/9829964/">https://pubmed.ncbi.nlm.nih.gov/9829964/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>NOD1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>iE_DAP</li>
          </ul>
        </td>
        <td>
          <p>Nucleotide-binding oligomerization domain-containing protein 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9Y239/entry">https://www.uniprot.org/uniprotkb/Q9Y239/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>iE_DAP</th>
              <td>
                <p>OD1 and NOD2 detect κ-d-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide (MDP), found in bacterial peptidoglycan, respectively. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/topics/immunology-and-microbiology/nod1">https://www.sciencedirect.com/topics/immunology-and-microbiology/nod1</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>iE_DAP</th>
        <td/>
        <td>no function</td>
        <td>
          <p>G-d-glutamyl-meso-diaminopimelic acid</p>
          <ol class="links">
            <li>
              <a href="https://pubmed.ncbi.nlm.nih.gov/28655577/">https://pubmed.ncbi.nlm.nih.gov/28655577/</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>RIPK2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NOD1 | NOD2</li>
          </ul>
        </td>
        <td>
          <p>Receptor-interacting serine/threonine-protein kinase 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O43353/entry">https://www.uniprot.org/uniprotkb/O43353/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NOD2</th>
              <td>
                <p>MDP activates NOD2 to initiate RIPK2 recruitment resulting in platform formation.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2016.00367/full">https://www.frontiersin.org/articles/10.3389/fimmu.2016.00367/full</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>NOD1</th>
              <td>
                <p>upon activation, NOD1 and NOD2 recruit RIPK2 through CARD domains (31, 32).</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536010/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>COX2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT3 | NFKB</li>
          </ul>
        </td>
        <td>
          <p>Cytochrome c oxidase subunit 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P00403/entry">https://www.uniprot.org/uniprotkb/P00403/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Canonical NF-κB pathway activation is well studied in IBD and is associated with the rapid, acute production of diverse pro-inflammatory mediators, such as COX-2, IL-1β, and IL-6.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992436/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992436/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>mTORC1 activates COX-2 transcription via phosphorylating STAT3 and enhancing it’s binding to the COX-2 promoter.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/s41385-018-0018-3">https://www.nature.com/articles/s41385-018-0018-3</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>PGE2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>COX2</li>
          </ul>
        </td>
        <td>
          <p></p>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>COX2</th>
              <td>
                <p>COX-2 derived PGs are involved in a variety of pathologic processes, including IBD<br />Multiple lines of evidence have demonstrated that PGE2 mediates the pro-inflammatory and tumor-promoting effects of COX-2 in IBD.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181054/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181054/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>DEFA6</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | AP1</li>
          </ul>
        </td>
        <td>
          <p>Defensin-6</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q01524/entry">https://www.uniprot.org/uniprotkb/Q01524/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CAMP</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | AP1</li>
          </ul>
        </td>
        <td>
          <p>Cathelicidin antimicrobial peptide</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P49913/entry">https://www.uniprot.org/uniprotkb/P49913/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TNFAIP3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>TNFAIP3/TNFAP3:Tumor necrosis factor alpha-induced protein 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P21580/entry">https://www.uniprot.org/uniprotkb/P21580/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>TNFα-induced protein 3 (TNFAIP3) is a NF-κB-induced gene that acts in a negative-feedback loop to inhibit NF-κB activation.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22595989/">https://pubmed.ncbi.nlm.nih.gov/22595989/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CXCL3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT3</li>
          </ul>
        </td>
        <td>
          <p>C-X-C motif chemokine 3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P19876/entry">https://www.uniprot.org/uniprotkb/P19876/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Muramyl dipeptide-induced increases in NOD2, interleukin-8, and CXCL3 expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/24297055/">https://pubmed.ncbi.nlm.nih.gov/24297055/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>Colonic expression of interleukin 6 (IL-6), the STAT3 target gene SOCS3, the neutrophil chemoattractants IL-8, CXCL1, and CXCL3, and the neutrophil products S100A8, S100A9, and S100A12 were increased in patients carrying the STAT3 "A" risk allele.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22197944/">https://pubmed.ncbi.nlm.nih.gov/22197944/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>S100A8</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT3</li>
          </ul>
        </td>
        <td>
          <p>Protein S100-A8</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P05109/entry">https://www.uniprot.org/uniprotkb/P05109/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>Colonic expression of interleukin 6 (IL-6), the STAT3 target gene SOCS3, the neutrophil chemoattractants IL-8, CXCL1, and CXCL3, and the neutrophil products S100A8, S100A9, and S100A12 were increased in patients carrying the STAT3 "A" risk allele.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22197944/">https://pubmed.ncbi.nlm.nih.gov/22197944/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>S100A9</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT3</li>
          </ul>
        </td>
        <td>
          <p>Protein S100-A9</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P06702/entry">https://www.uniprot.org/uniprotkb/P06702/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>Colonic expression of interleukin 6 (IL-6), the STAT3 target gene SOCS3, the neutrophil chemoattractants IL-8, CXCL1, and CXCL3, and the neutrophil products S100A8, S100A9, and S100A12 were increased in patients carrying the STAT3 "A" risk allele.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/22197944/">https://pubmed.ncbi.nlm.nih.gov/22197944/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNA1_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interferon alpha-1/13</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01562/entry">https://www.uniprot.org/uniprotkb/P01562/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IFNG</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1</li>
          </ul>
        </td>
        <td>
          <p>Interferon gamma</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01579/entry">https://www.uniprot.org/uniprotkb/P01579/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/gene/6772">https://www.ncbi.nlm.nih.gov/gene/6772</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNG_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interferon gamma</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01579/entry">https://www.uniprot.org/uniprotkb/P01579/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IFNGR</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IFNG_e</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Interferon gamma receptor 1<br />Interferon gamma receptor 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P15260/entry">https://www.uniprot.org/uniprotkb/P15260/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P38484/entry">https://www.uniprot.org/uniprotkb/P38484/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IFNG_e</th>
              <td>
                <p>This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/gene/3459#summary">https://www.ncbi.nlm.nih.gov/gene/3459#summary</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>JAK1_JAK2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IFNGR &amp; !PTPN2</li>
          </ul>
        </td>
        <td>
          <p>Tyrosine-protein kinase JAK1<br />Tyrosine-protein kinase JAK2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P23458/entry">https://www.uniprot.org/uniprotkb/P23458/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/O60674/entry">https://www.uniprot.org/uniprotkb/O60674/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>PTPN2</th>
              <td>
                <p>The PTPN2 gene encodes the T-cell<br />protein tyrosine phosphatase (TCPTP), which is essential for regulation of in-<br />flammation. TCPTP partly modulates inflammation via control of inflamma-<br />tory signaling pathways, by namely inhibiting Janus kinase (JAK) enzymes,<br />and signal transducer and activator of transcription (STAT) molecules.</p>
                <ol class="links">
                  <li>
                    <a href="https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/">https://researchoutreach.org/articles/inflammatory-bowel-disease-epithelial-barrier-function/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IFNGR</th>
              <td>
                <p>IFNGR1 binds to JAK1 whereas IFNGR2 binds to JAK2. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165917/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IFNA1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IRF_complex | IRF1</li>
          </ul>
        </td>
        <td>
          <p>Interferon alpha-1/13</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01562/entry">https://www.uniprot.org/uniprotkb/P01562/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IRF1</th>
              <td>
                <p>IRF1 is a transcription factor that can provide additional positive feedback stimulation of ISGs.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35790340/">https://pubmed.ncbi.nlm.nih.gov/35790340/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>IRF_complex</th>
              <td>
                <p>IRF3/7 are activated leading to the induction of pro-inflammatory cytokines and type I and III IFNs. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2020.608645/full">https://www.frontiersin.org/articles/10.3389/fimmu.2020.608645/full</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>mTORC1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>AKT &amp; !TSC1</li>
          </ul>
        </td>
        <td>
          <p>mTORC1 complex</p>
          <ol class="links">
            <li>
              <a href="https://www.ebi.ac.uk/complexportal/complex/CPX-503">https://www.ebi.ac.uk/complexportal/complex/CPX-503</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>AKT inhibits GTPase-activating protein (GAP) activity by phosphorylating TSC2, which leads to activation of the mTOR complex. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.spandidos-publications.com/10.3892/ijmm.2014.1981">https://www.spandidos-publications.com/10.3892/ijmm.2014.1981</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>TSC1</th>
              <td>
                <p>TSC1, a key negative upstream regulator of mTORC1. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.nature.com/articles/s41385-018-0018-3">https://www.nature.com/articles/s41385-018-0018-3</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>TSC1</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Hamartin</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q92574/entry">https://www.uniprot.org/uniprotkb/Q92574/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>PPARG</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!IKBKB</li>
          </ul>
        </td>
        <td>
          <p>Peroxisome proliferator-activated receptor gamma</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P37231/entry">https://www.uniprot.org/uniprotkb/P37231/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IKBKB</th>
              <td>
                <p> IKK acts through at least two mechanisms: inhibition of PPARgamma expression and activation of PPARgamma corepressor. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/18655773/">https://pubmed.ncbi.nlm.nih.gov/18655773/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>BAD</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>!AKT</li>
          </ul>
        </td>
        <td>
          <p>Bcl2-associated agonist of cell death</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q92934/entry">https://www.uniprot.org/uniprotkb/Q92934/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>Akt phosphorylates BAD in vitro and in vivo, and blocks the BAD-induced death.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/9346240/">https://pubmed.ncbi.nlm.nih.gov/9346240/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CLDN2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1</li>
          </ul>
        </td>
        <td>
          <p>Claudin domain-containing protein 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q8NHS1/entry">https://www.uniprot.org/uniprotkb/Q8NHS1/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>t IL-22 increases intestinal epithelial permeability by upregulating Claudin-2 expression through the JAK/STAT pathway. </p>
                <ol class="links">
                  <li>
                    <a href="https://www.jimmunol.org/content/199/9/3316">https://www.jimmunol.org/content/199/9/3316</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CASP3</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>CASP8 | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Caspase-3</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P42574/entry">https://www.uniprot.org/uniprotkb/P42574/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>CASP8</th>
              <td>
                <p>The effector caspases, caspase-3 and caspase-7, exist as dimeric zymogens that are activated by cleavage between their large and small subunits. Fully matured caspase-8 cleaves these zymogens and thus activates them.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417704/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417704/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>These apoptosis ISGs were predominantly proapoptotic genes (including BAK1, CASP3, CASP8, CASP10, FAS, TNFSF10A, and TNFRSF10A) and were stimulated by IFN-II or IFN-I treatments.</p>
                <ol class="links">
                  <li>
                    <a href="https://journals.aai.org/immunohorizons/article/6/7/416/234080/Transcriptional-and-Cytotoxic-Responses-of-Human">https://journals.aai.org/immunohorizons/article/6/7/416/234080/Transcriptional-and-Cytotoxic-Responses-of-Human</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL1R</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IL1b_e</li>
          </ul>
        </td>
        <td>
          <p>complex:<br /><br />Interleukin-1 receptor type 1<br />Interleukin-1 receptor accessory protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P14778/entry">https://www.uniprot.org/uniprotkb/P14778/entry</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9NPH3/entry">https://www.uniprot.org/uniprotkb/Q9NPH3/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IL1b_e</th>
              <td>
                <p> The data show that the initial translation product from IL-1 beta mRNA must be processed in order to bind to the IL-1 receptor and hence express biological activity.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/2950091/">https://pubmed.ncbi.nlm.nih.gov/2950091/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>DEFA5</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | AP1</li>
          </ul>
        </td>
        <td>
          <p>Defensin alpha 5</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q01523/entry">https://www.uniprot.org/uniprotkb/Q01523/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p>The MAPK, NF-κB and HDAC signaling pathways play vital roles in the induction of defensin and cathelicidin expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X">https://www.sciencedirect.com/science/article/abs/pii/S019697811930155X</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IL1b_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interleukin-1 beta</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P01584/entry">https://www.uniprot.org/uniprotkb/P01584/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>MHC_II</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1</li>
          </ul>
        </td>
        <td>
          <p>peptide antigen assembly with MHC class II protein complex</p>
          <ol class="links">
            <li>
              <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002503">https://www.ebi.ac.uk/QuickGO/term/GO:0002503</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>Accordingly, pre-treatment of colonoids with IBD-approved pan-Janus Kinase (JAK) inhibitor Tofacitinib led to the downregulation of TNF+Poly(I:C)-dependent MHC-II expression associated with the abrogation of STAT1 activation. </p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35655783/">https://pubmed.ncbi.nlm.nih.gov/35655783/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>REG3A</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT3 | AP1</li>
          </ul>
        </td>
        <td>
          <p>Regenerating islet-derived protein 3-alpha</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q06141/entry">https://www.uniprot.org/uniprotkb/Q06141/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Once our body suffered injury, infection or other stimuli, REG3A expression was induced through the recognition receptor and adaptors, including TLR, IL-17RA, IL-22R, SCFA receptor or MyD88.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>Once our body suffered injury, infection or other stimuli, REG3A expression was induced through the recognition receptor and adaptors, including TLR, IL-17RA, IL-22R, SCFA receptor or MyD88.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>AP1</th>
              <td>
                <p>Once our body suffered injury, infection or other stimuli, REG3A expression was induced through the recognition receptor and adaptors, including TLR, IL-17RA, IL-22R, SCFA receptor or MyD88.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825409/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>DUOX2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Dual oxidase 2</p>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p> WT colonoid stimulation with IFNγ and the Crohn’s disease-associated pathobiont AIEC induced Duox2 and Duoxa2 expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416">https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p> WT colonoid stimulation with IFNγ and the Crohn’s disease-associated pathobiont AIEC induced Duox2 and Duoxa2 expression.</p>
                <ol class="links">
                  <li>
                    <a href="https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416">https://academic.oup.com/ibdjournal/article/27/Supplement_1/S26/6105416</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IDO1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT1</li>
          </ul>
        </td>
        <td>
          <p>Indoleamine 2,3-dioxygenase 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P14902/entry">https://www.uniprot.org/uniprotkb/P14902/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>IDO1 expression is stimulated by inflammatory cytokines including IFNγ, TNFα and IL1-B. Consistent with this, IDO1 is one of the most highly upregulated genes in human IBD and animal models of colitis.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686557/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686557/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>IDO1 expression is stimulated by inflammatory cytokines including IFNγ, TNFα and IL1-B. Consistent with this, IDO1 is one of the most highly upregulated genes in human IBD and animal models of colitis.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686557/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686557/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>LCN2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB | STAT3</li>
          </ul>
        </td>
        <td>
          <p>LCN2/NGAL: Neutrophil gelatinase-associated lipocalin</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P80188/entry">https://www.uniprot.org/uniprotkb/P80188/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>IL-17A showed a synergistic effect with IL-22 and TNF-α in inducing colonic epithelial expression of LCN2.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26263469/">https://pubmed.ncbi.nlm.nih.gov/26263469/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT3</th>
              <td>
                <p>IL-17A showed a synergistic effect with IL-22 and TNF-α in inducing colonic epithelial expression of LCN2.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26263469/">https://pubmed.ncbi.nlm.nih.gov/26263469/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>MMP7</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>Matrilysin</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P09237/entry">https://www.uniprot.org/uniprotkb/P09237/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>IL-1β, IL-4, IL-13, TNFα, or lipopolysaccharide enhanced MMP-7 expression in human colonic epithelial cells.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36275703/">https://pubmed.ncbi.nlm.nih.gov/36275703/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>SAA2</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>NFKB</li>
          </ul>
        </td>
        <td>
          <p>Serum amyloid A-2 protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P0DJI9/entry">https://www.uniprot.org/uniprotkb/P0DJI9/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>Elevated systemic concentrations of both A-SAA and tumour necrosis factor (TNF)-α are a feature of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/14871291/">https://pubmed.ncbi.nlm.nih.gov/14871291/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CXCL9</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1</li>
          </ul>
        </td>
        <td>
          <p>C-X-C motif chemokine 9</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q07325/entry">https://www.uniprot.org/uniprotkb/Q07325/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>In epithelial colonic cells CXCL9 expression is increased by IFN-γ.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30393811/">https://pubmed.ncbi.nlm.nih.gov/30393811/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>Tollip</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Toll-interacting protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q9H0E2/entry">https://www.uniprot.org/uniprotkb/Q9H0E2/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>PTPN2</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Tyrosine-protein phosphatase non-receptor type 2</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P17706/entry">https://www.uniprot.org/uniprotkb/P17706/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IFNL1_e</th>
        <td/>
        <td>no function</td>
        <td>
          <p>Interferon lambda-1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q8IU54/entry">https://www.uniprot.org/uniprotkb/Q8IU54/entry</a>
            </li>
          </ol>
        </td>
      </tr>
      <tr>
        <th>IFNLR</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>IFNL1_e</li>
          </ul>
        </td>
        <td>
          <p>Interleukin-10 receptor subunit beta<br />Interferon lambda receptor 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q08334/feature-viewer">https://www.uniprot.org/uniprotkb/Q08334/feature-viewer</a>
            </li>
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q8IU57/entry">https://www.uniprot.org/uniprotkb/Q8IU57/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>IFNL1_e</th>
              <td>
                <p>IFN-λ signaling through the IFN-λ-receptor (IFNλR) on IECs.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2017.00749/full">https://www.frontiersin.org/articles/10.3389/fimmu.2017.00749/full</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>ISG20</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>ISGF3</li>
          </ul>
        </td>
        <td>
          <p>Interferon-stimulated gene 20 kDa protein</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/Q96AZ6/entry">https://www.uniprot.org/uniprotkb/Q96AZ6/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>ISGF3</th>
              <td>
                <p>IFN-stimulated gene factor 3 (ISGF3) which binds to IFN-stimulated response DNA element (ISRE) and induces transcription of ISGs.</p>
                <ol class="links">
                  <li>
                    <a href="Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.">Østvik AE, Svendsen TD, Granlund AVB, Doseth B, Skovdahl HK, Bakke I, Thorsvik S, Afroz W, Walaas GA, Mollnes TE, Gustafsson BI, Sandvik AK, Bruland T. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease. J Crohns Colitis. 2020 Jul 30;14(7):920-934. doi: 10.1093/ecco-jcc/jjaa022. PMID: 32020185; PMCID: PMC7392169.</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>IRF1</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1</li>
          </ul>
        </td>
        <td>
          <p>Interferon regulatory factor 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P10914/entry">https://www.uniprot.org/uniprotkb/P10914/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>We treated organoids from ileum, ascending colon, and sigmoid colon of subject 005 with titrations of IFN-I, IFN-II, or IFN-III and observed that CXCL10 and IRF1 were stimulated to the greatest extent by IFN-II treatment.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35790340/">https://pubmed.ncbi.nlm.nih.gov/35790340/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CXCL10</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>STAT1 | NFKB</li>
          </ul>
        </td>
        <td>
          <p>C-X-C motif chemokine 10</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P02778/entry">https://www.uniprot.org/uniprotkb/P02778/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>NFKB</th>
              <td>
                <p>These data demonstrate that in colonic epithelial cells, depending on the cellular context and utilizing the NF-κB pathway, IL-1β alone and/or in synergism with IFN-γ may play a major role in the induction of CXCL10.</p>
                <ol class="links">
                  <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225996/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225996/</a>
                  </li>
                </ol>
              </td>
            </tr>
            <tr>
              <th>STAT1</th>
              <td>
                <p>We treated organoids from ileum, ascending colon, and sigmoid colon of subject 005 with titrations of IFN-I, IFN-II, or IFN-III and observed that CXCL10 and IRF1 were stimulated to the greatest extent by IFN-II treatment.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35790340/">https://pubmed.ncbi.nlm.nih.gov/35790340/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <th>CDKN1A</th>
        <td>1</td>
        <td>
          <ul class="L1">
            <li>AKT</li>
          </ul>
        </td>
        <td>
          <p>Cyclin-dependent kinase inhibitor 1</p>
          <ol class="links">
            <li>
              <a href="https://www.uniprot.org/uniprotkb/P38936/entry">https://www.uniprot.org/uniprotkb/P38936/entry</a>
            </li>
          </ol>
          <table name="" class="">
            <tr class="">
              <th>Regulator</th>
              <th>Comment</th>
            </tr>
            <tr>
              <th>AKT</th>
              <td>
                <p>Whereas Akt1 phosphorylates p21.</p>
                <ol class="links">
                  <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/16982699/">https://pubmed.ncbi.nlm.nih.gov/16982699/</a>
                  </li>
                </ol>
              </td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
  </body>
</html>
